Patents by Inventor Christine Marie Mack

Christine Marie Mack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods For Affecting Body Composition
    Publication number: 20140066368
    Abstract: Methods for affecting body composition include the use of amylin or amylin agonist(s). Total body weight be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.
    Type: Application
    Filed: August 20, 2013
    Publication date: March 6, 2014
    Applicants: AstraZeneca Pharmaceuticals, LP, Amylin Pharmaceuticals, LLC
    Inventors: Christine Marie Mack, Jonathan David Roth
  • AMYLIN FAMILY PEPTIDES AND METHODS FOR MAKING AND USING THEM
    Publication number: 20120196796
    Abstract: The present invention relates to novel compounds having a function of a peptide in the amylin family, related nucleic acids, expression constructs, host cells, and processes production of the compounds. The compounds of the invention include one or more amino acid sequence modifications. In addition, methods and compositions are disclosed to treat and prevent metabolic disorders such as obesity, diabetes, and increased cardiovascular risk.
    Type: Application
    Filed: February 1, 2012
    Publication date: August 2, 2012
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Christopher J. Soares, Michael R. Hanley, Diana Yvonne Lewis, David Geoffrey Parkes, Carolyn Marie Jodka, Kathryn S. Prickett, Soumitra Ghosh, Christine Marie Mack, Qing Lin
  • Amylin family peptides
    Patent number: 8114958
    Abstract: The present invention relates to obesity related polypeptides (ORPs), related nucleic acids, expression constructs, host cells, and processes production of the obesity related polypeptides. The ORPs of the invention include one or more amino acid sequence modifications. In addition, methods and compositions are disclosed to treat and prevent metabolic disorders such as obesity, diabetes, and increased cardiovascular risk.
    Type: Grant
    Filed: February 11, 2005
    Date of Patent: February 14, 2012
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Christopher J. Soares, Michael R. Hanley, Diana Y. Lewis, David Geoffrey Parkes, Carolyn M. Jodka, Kathryn S. Prickett, Soumitra S. Ghosh, Christine Marie Mack, Qing Lin
  • Amylin Family Peptides And Methods For Making And Using Them
    Publication number: 20080274952
    Abstract: The present invention relates to obesity related polypeptides (ORPs), related nucleic acids, expression constructs, host cells, and processes production of the obesity related polypeptides. The ORPs of the invention include one or more amino acid sequence modifications. In addition, methods and compositions are disclosed to treat and prevent metabolic disorders such as obesity, diabetes, and increased cardiovascular risk.
    Type: Application
    Filed: February 11, 2005
    Publication date: November 6, 2008
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Christopher J Soares, Michael R. Hanley, Diana Yvonne Lewis, David Geoffrey Parkes, Carolyn Marie Jodka, Kathryn S. Prickett, Soumitra Ghosh, Christine Marie Mack, Qing Lin
  • Methods for Affecting Body Composition
    Publication number: 20080176804
    Abstract: Methods for affecting body composition include the use of amylin or amylin agonist(s). Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.
    Type: Application
    Filed: March 25, 2008
    Publication date: July 24, 2008
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Christine Marie Mack, Jonathan David Roth
  • Methods for affecting body composition
    Patent number: 7399744
    Abstract: Methods for affecting body composition include the use of amylin or amylin agonist(s). Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.
    Type: Grant
    Filed: May 20, 2004
    Date of Patent: July 15, 2008
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Christine Marie Mack, Jonathan David Roth